Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydralazine as Demethylating Agent in Breast Cancer
NCT00575978Phase 2Withdrawn
- Sponsor
- University of Arkansas
- Start
- Jun 2004
- Primary completion
- Dec 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of hydralazine in breast cancer, sponsored by University of Arkansas. Planned start Jun 2004; status: withdrawn.
02
Drugs
hydralazine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00575978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00575978.